Q1FY27 Results: Revenue up 13.9% YoY at INR 747 Mn, PAT rises 23.8%
LAXMIDENTL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 3.7 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Laxmi Dental reported highest-ever quarterly revenue of INR 747 Mn in Q1FY27, up 13.9% YoY from INR 656 Mn. EBITDA grew 20.6% YoY to INR 143.6 Mn with margin expanding to 19.2% from 18.2%. PAT rose 23.8% YoY to INR 103.2 Mn. Dental laboratory business grew 23.5% YoY with international operations up 37.4%. Aligner Solutions grew 28.6% YoY. Gross margins improved to 78.6% on better product mix.
Strong quarter with highest-ever revenue, margin expansion, and broad-based growth across dental lab and aligner businesses.